Delivery of RNA interference

被引:163
|
作者
Li, Charles X. [1 ]
Parker, Amy [1 ]
Menocal, Ellen [1 ]
Xiang, Shuanglin [1 ]
Borodyansky, Laura [1 ]
Fruehauf, Johannes H. [1 ]
机构
[1] Harvard Univ, Sch Med, Div Gastroenterol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
RNA interference; gene therapy; gene delivery; therapeutic RNAi; transkingdom RNA interference;
D O I
10.4161/cc.5.18.3192
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the last few years, RNA Interference (RNAi), a naturally occurring mechanism of gene regulation conserved in plant and mammalian cells, has opened numerous novel opportunities for basic research across the field of biology. While RNAi has helped accelerate discovery and understanding of gene functions, it also has great potential as a therapeutic and potentially prophylactic modality. Challenging diseases failing conventional therapeutics could become treatable by specific silencing of key pathogenic genes. More specifically, therapeutic targets previously deemed "undruggable" by small molecules, are now coming within reach of RNAi based therapy. For RNAi to be effective and elicit gene silencing response, the double-stranded RNA molecules must be delivered to the target cell. Unfortunately, delivery of these RNA duplexes has been challenging, halting rapid development of RNAi-based therapies. In this review we present current advancements in the field of siRNA delivery methods, including the pros and cons of each method.
引用
收藏
页码:2103 / 2109
页数:7
相关论文
共 50 条
  • [31] RNA Interference in Neuroscience: Progress and Challenges
    Victor M. Miller
    Henry L. Paulson
    Pedro Gonzalez-Alegre
    Cellular and Molecular Neurobiology, 2005, 25 : 1195 - 1207
  • [32] RNA interference: ready to silence cancer?
    Mocellin, S
    Costa, R
    Nitti, D
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2006, 84 (01): : 4 - 15
  • [33] RNA interference: ready to silence cancer?
    Simone Mocellin
    Rodolfo Costa
    Donato Nitti
    Journal of Molecular Medicine, 2006, 84 : 4 - 15
  • [34] Development of strategies for conditional RNA interference
    Allen, Danny
    Kenna, Paul F.
    Palfi, Arpad
    McMahon, Helena P.
    Millington-Ward, Sophia
    O'Reilly, Mary
    Humphries, Peter
    Farrar, G. Jane
    JOURNAL OF GENE MEDICINE, 2007, 9 (04) : 287 - 298
  • [35] THERAPEUTIC RNA INTERFERENCE FOR NEURODEGENERATIVE DISEASES
    Gonzalez-Alegre, P.
    REVISTA DE NEUROLOGIA, 2008, 47 (12) : 641 - 647
  • [36] RNA interference in neuroscience: Progress and challenges
    Miller, VM
    Paulson, HL
    Gonzalez-Alegre, P
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (08) : 1195 - 1207
  • [37] Induction of RNA interference in dendritic cells
    Mu Li
    Hua Qian
    Thomas E. Ichim
    Wei-Wen Ge
    Igor A. Popov
    Katarzyna Rycerz
    John Neu
    David White
    Robert Zhong
    Wei-Ping Min
    Immunologic Research, 2004, 30 : 215 - 230
  • [38] Engineering mucosal RNA interference in vivo
    Zhang, Yingjie
    Cristofaro, Patricia
    Silbermann, Rebecca
    Pusch, Oliver
    Boden, Daniel
    Konkin, Tamako
    Hovanesian, Virginia
    Monfils, Paul R.
    Resnick, Murray
    Moss, Steven F.
    Ramratnam, Bharat
    MOLECULAR THERAPY, 2006, 14 (03) : 336 - 342
  • [39] The Delivery of RNA-Interference Therapies Based on Engineered Hydrogels for Bone Tissue Regeneration
    Yu, Tingting
    Wang, Hufei
    Zhang, Yunfan
    Wang, Xing
    Han, Bing
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [40] Basic Principles of RNA Interference: Nucleic Acid Types and In Vitro Intracellular Delivery Methods
    Isenmann, Marie
    Stoddart, Martin James
    Schmelzeisen, Rainer
    Gross, Christian
    Della Bella, Elena
    Rothweiler, Rene Marcel
    MICROMACHINES, 2023, 14 (07)